Shionogi & Co Ltd (SGIOF) Q3 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Shionogi & Co., Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:01.553 This 00:00:01.553 -- 00:00:06.021 is Kyokawa of the Corporate Communication Department of Shionogi. 00:00:06.021 -- 00:00:10.989 Thank you very much for gathering today. From now, we would like to begin the presentation 00:00:10.989 -- 00:00:16.117 of the third quarter of fiscal 2024 financial results from Shionogi and 00:00:16.117 -- 00:00:21.440 Company Limited. First of all, let me introduce the people who are 00:00:21.440 -- 00:00:26.808 here with us. First of all, Toshinobu Iwasaki, Senior Executive Officer, Healthcare Business 00:00:26.808 -- 00:00:30.354 Supervisory Unit. Next, 00:00:30.354 -- 00:00:32.216 Koji Hanasaki, 00:00:32.216 -- 00:00:36.924 Senior Executive Officer of Supply Supervisory Unit. 00:00:36.924 -- 00:00:38.924 Next 00:00:39.728 -- 00:00:44.916 is Kazuhiro Hatanaka, Senior Executive Officer, Corporate Supervisory 00:00:44.916 -- 00:00:50.042 Unit and Corporate Strategy Division. And next is Takeki 00:00:50.042 -- 00:00:56.968 Uehara, Corporate Officer of Drug Development and Regulatory Science Division. 00:00:59.292 -- 00:01:01.292 Uehara-san 00:01:03.857 -- 00:01:07.639 is joining from different 00:01:08.102 -- 00:01:13.328 venue online. And we have Masako Kudo from the Finance 00:01:13.328 -- 00:01:15.260 and Accounting Department. 00:01:15.260 -- 00:01:17.260 Let 00:01:17.678 -- 00:01:20.963 me briefly explain the flow of today's meeting. 00:01:20.963 -- 00:01:26.850 First of all, we would like to give you the overview of the Q3 00:01:26.850 -- 00:01:31.976 FY2024 financial results and transformation of Chinese business 00:01:31.976 -- 00:01:38.081 and pipeline progress will be explained, and we will have Q&A session after that. 00:01:39.545 -- 00:01:44.651 We will have a simultaneous interpretation ser...